Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,737 | 63,502 | 130,481 | 52,651 | 40,793 |
| Marketable Securities | 150,404 | 122,026 | 70,770 | 164,293 | 195,815 |
| TOTAL | $197,453 | $192,695 | $208,679 | $218,557 | $238,490 |
| Non-Current Assets | |||||
| PPE Net | 11,205 | 10,585 | 17,385 | 17,658 | 19,714 |
| Other Non-Current Assets | 796 | 1,080 | 793 | 794 | 796 |
| TOTAL | $12,001 | $11,665 | $18,178 | $18,452 | $20,510 |
| Total Assets | $209,454 | $204,360 | $226,857 | $237,009 | $259,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,502 | 3,475 | 3,339 | 3,314 | 3,256 |
| Accounts payable and accrued liabilities | 5,573 | 3,754 | 2,871 | 2,982 | 3,307 |
| Accrued Expenses | 14,967 | 12,418 | 11,306 | 5,622 | 5,925 |
| TOTAL | $24,042 | $19,647 | $17,516 | $11,918 | $12,488 |
| Non-Current Liabilities | |||||
| Long Term Debt | 983 | 1,872 | 2,836 | 3,659 | 4,486 |
| Other Non-Current Liabilities | 2,182 | 2,122 | 2,109 | 1,942 | 1,428 |
| TOTAL | $6,741 | $7,642 | $8,626 | $9,315 | $9,660 |
| Total Liabilities | $30,783 | $27,289 | $26,142 | $21,233 | $22,148 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,273 | 29,319 | 28,515 | 28,485 | 28,467 |
| Common Shares | 30 | 29 | 29 | 28 | 28 |
| Retained earnings | -448,736 | -421,543 | -394,741 | -376,762 | -352,161 |
| Other shareholders' equity | -98 | -45 | 16 | 148 | 186 |
| TOTAL | $178,671 | $177,071 | $200,715 | $215,776 | $236,852 |
| Total Liabilities And Equity | $209,454 | $204,360 | $226,857 | $237,009 | $259,000 |